Frequency and antibiotic susceptibility patterns of urinary pathogens in male outpatients in Argentina

Journal of Infection in Developing Countries

Volumn 8, Issue 6, 2014, Pages 699-704

  Villar, Hugo E ^a   Jugo, Mónica B ^a   Macan, Alejandro ^b,c   Visser, Matías ^a   Hidalgo, Mariana ^a   Maccallini, Gustavo Cesar ^a  

^a Laboratorio Hidalgo   (Argentina)

^b Martinez Medical Center   (Argentina)

^c Martin y Omar Medical Center   (Argentina)

Author keywords

Antimicrobial susceptibility; Community acquired urinary tract; Empirical treatment; Infection; Uropathogen

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMPICILLIN; CEFALOTIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN; GLUCOSE 6 PHOSPHATE; IMIPENEM; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARGENTINA; ARTICLE; BACTERIUM; BACTERIUM ISOLATION; BACTERIURIA; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DISK DIFFUSION; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MORGANELLA MORGANII; OUTPATIENT; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; URINALYSIS; URINARY TRACT; URINE CULTURE; VERY ELDERLY; ANTIBIOTIC RESISTANCE; DEVELOPING COUNTRY; ESCHERICHIA COLI INFECTIONS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; URINARY TRACT INFECTIONS;

AGED; AGED, 80 AND OVER; ARGENTINA; BACTERIURIA; DEVELOPING COUNTRIES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OUTPATIENTS; URINARY TRACT INFECTIONS;

EID: 84902303871     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.3766     Document Type: Article

References (24)

1. Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD (2000) Urinary tract infection: self-reported incidence and associated costs. Ann Epidem 10: 509-515.
2. Litwin MS, Saigal CS, Yano EM Avila C, Geschwind SA, Hanley JM, Joyce GF, Madison R, Pace J, Polich SM, Wang M (2005) Urologic diseases in America project: analytical methods and principal findings. J Urol 173: 933-937.
3. Hooton TM, Stamm WE (1997) Diagnosis and treatment of acute uncomplicated urinary tract infection. Infec Dis Clin North Am 11: 551-581.
4. Huang ES, Stafford RS (2002) National patterns in the treatment of urinary tract infections in women by ambulatory care physicians. Arch Intern Med 14: 1-47.
5. Griebling TL (2005) Urologic diseases in America project: trends in resource use for urinary tract infections in men. J Urol 173:1288-1294.
6. Tal S, Guller V, Levi S, Bardenstein R, Berger D, Gurevich I, Gurevich A (2005) Profile and prognosis of febrile elderly patients with bacteremic urinary tract infections. J Infect 50: 296-305.
7. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE (1999) Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelo¬nephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 29: 745-758.
8. Gupta K, Hooton TM, Wobbe CL Stamm WE (1999) The prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in young women. Int. J. Antimicrob. Agents 11: 305-308.
9. Sahm DF, Thornsberry C, Mayfield DC, Jones ME, Karlowsky JA (2001) Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob. Agents Chemother. 45: 1402-1406.
10. Clinical and Laboratory Standards Institute (2012) Performance standards for antimicrobial susceptibility testing; Twenty-Second informational supplement M100-S22. CLSI, Wayne, PA.
11. Clinical and Laboratory Standards Institute (2009) Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement, M100-S19. CLSI, Wayne (PA).
12. Koeijers JJ, Verbon A, Kessels AG Bartelds A, Donkers G, Nys S, Stobberingh EE (2010) Urinary tract infection in male general practice patients: uropathogens and antibiotic susceptibility. Urology 76: 336-340
13. Rocha JL, Tuon FF, Johnson JR (2012) Sex, drugs, bugs, and age: rational selection of empirical therapy for outpatient urinary tract infection in an era of extensive antimicrobial resistance. Braz J Infect Dis 16: 115-121.
14. Lorente Garìn JA, Placer Santos J, Salvadó Costa M, Segura Alvarez C, Gelabert-Mas A (2005) Evolución de la resistencia antibiótica en las infecciones urinarias adquiridas en la comunidad. Rev Clin Esp 205: 259-264.
15. Zhanel GG, Hisanaga TL, Laing NM DeCorby MR, Nichol KA, Weshnoweski B, Johnson J, Noreddin A, Low DE, Karlowsky JA; NAUTICA Group, Hoban DJ (2006) Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 27: 468-475.
16. Kiffer CR, Mendes C, Oplustil CP, Sampaio JL (2007) Antibiotic resistance and trend of urinary pathogens in general outpatients from a major urban city. International Braz J Urol 33: 42-49.
17. McCaig LF, Besser RE, Hughes JM (2003) Antimicrobial drug prescription in ambulatory care settings, United States 1992-2000. Emerg Infect Dis 9: 432-437.
18. Meier S, Weber R, Zbiden R, Ruef C, Hasse B (2011) Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Infection 39: 333-340.
19. Oteo J, Pérez-Vázquez M, Campos J (2010) Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis 23: 320-326.
20. Knottnerus BJ, Nys S, Ter Riet G, Donker G, Geerlings SE, Stobberingh E (2008) Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands? J Antimicrob Chemother 62: 356-359.
21. Garau M, Latorrey A, Alonso-Sanz M (2001) Fosfomicina: un antibiótico infravalorado en infecciones urinarias por Escherichia coli. Enferm Infecc Microbiol Clin 19: 462-426.
22. García García MI, Muñoz Bellido JL, García Rodríguez JA (2007) In vitro susceptibility of community-acquired urinary tract infection pathogens to commonly used antimicrobial agents in Spain. Acomparative multricenter study (2002-2004). J Chemother 19: 263-270.
23. Alós JI, Serrano MG, Gómez Garcés JL, Perianes J (2005) Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data. Clin Microbiol Infect 1: 199-203.
24. Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF (2002) Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States Antimicrob Agents Chemother 46: 2540-2555.